Hundred-billion-level compound library + end-to-end screening, GalaxyVS has taken the infrastructure for new drug development to a new level.

View Original
MarsBitNews
Driving innovation in drug development, artificial intelligence virtual screening platform launched in Tianjin
Mars Finance News, May 30 — The AI virtual screening platform for ultra-large-scale drug discovery — GalaxyVS — was officially launched today.
The platform relies on the new generation Tianhe supercomputing system, targeting nearly one trillion synthesizable compound spaces, and has built an end-to-end technical system covering molecular characterization, vector retrieval, diversity control, affinity re-ranking, and large-scale task scheduling, providing a high-efficiency, high-precision, scalable new foundational platform for innovative drug development.
(Xinhua News Agency)
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned